Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Shares Fall 34 Percent After Company Withdraws 2006, 2007 Guidance

NEW YORK, June 22 (GenomeWeb News) - Gene Logic's stock price plummeted 33.7 percent, or $.68, to $1.34 per share in afternoon trading after the company withdrew its previously issued financial guidance for 2006 and 2007.


As reported by GenomeWeb News this morning, the company said its genomics revenue would be "significantly lower" than previously expected for both the second quarter 2006 and the entire year.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.